Regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathies

Journal of Parkinson's Disease · Published 2026-07-24 · DOI 10.1177/1877718x261463936

Free full text

Authors (11)

Diane Stephenson, Luis Concha-Marambio, Tom Lanz, Kalpana Merchant, Kathrin Brockmann, Nicholas King, Laura Carrillo, Anne Pedata, Harsha Kocherla, Samantha J Hutten, on behalf of the Critical Path for Parkinson's Consortium

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Stephenson, D., Concha-Marambio, L., Lanz, T., et al. (2026). Regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathies. Journal of Parkinson's Disease. https://doi.org/10.1177/1877718x261463936

Related articles

• Celebrating the legacy of two decades of Parkinson's disease research in South Africa · Journal of Parkinson's Disease · 2026 · Same journal
• Practical approaches to inclusive recruitment practices in Parkinson's disease research · Journal of Parkinson's Disease · 2026 · Same journal
• Structural biology of alpha-synuclein amyloid filaments: Implications in synucleinopathies · Journal of Parkinson's Disease · 2026 · Same journal
• Clinical GDNF delivery methods for Parkinson's disease · Journal of Parkinson's Disease · 2026 · Same journal
• Differential effects of levodopa on social cognition in people with Parkinson's disease · Journal of Parkinson's Disease · 2026 · Same journal
• Greater burden of Alzheimer's Co-pathology in women with Parkinson's disease dementia · Journal of Parkinson's Disease · 2026 · Same journal
• Parkinson's disease and the concept of resilience, cognitive, and motor reserve · Journal of Parkinson's Disease · 2026 · Same journal
• Digital profiling of dysarthria in late- and early-onset Parkinson's disease · Journal of Parkinson's Disease · 2026 · Same journal
• Crowdsourcing and machine learning contests in Parkinson's disease research - when do they work? · Journal of Parkinson's Disease · 2026 · Same journal
• Impact and management of cognition on speech and swallow function in Parkinson's disease · Journal of Parkinson's Disease · 2026 · Same journal